| 0 (0%) | 09-27 11:14 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 43.61 | 1-year : | 50.93 |
| Resists | First : | 37.33 | Second : | 43.61 |
| Pivot price | 36.22 |
|||
| Supports | First : | 34.58 | Second : | 32.88 |
| MAs | MA(5) : | 36.1 |
MA(20) : | 35.89 |
| MA(100) : | 30.53 |
MA(250) : | 25.3 |
|
| MACD | MACD : | 0.7 |
Signal : | 0.9 |
| %K %D | K(14,3) : | 40.5 |
D(3) : | 48.5 |
| RSI | RSI(14): 60.2 |
|||
| 52-week | High : | 37.33 | Low : | 17.81 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ KNSA ] has closed below upper band by 37.5%. Bollinger Bands are 53.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 36.64 - 36.82 | 36.82 - 37 |
| Low: | 34.96 - 35.15 | 35.15 - 35.33 |
| Close: | 36.19 - 36.49 | 36.49 - 36.79 |
Fri, 26 Sep 2025
Voya Investment Management LLC Buys 10,878 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Thu, 25 Sep 2025
Wells Fargo Raises KNSA Price Target to $45, Maintains Overweigh - GuruFocus
Thu, 25 Sep 2025
New Analyst Forecast: $KNSA Given $45.0 Price Target - Quiver Quantitative
Thu, 25 Sep 2025
Wells Fargo & Company Forecasts Strong Price Appreciation for Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - MarketBeat
Tue, 23 Sep 2025
Strs Ohio Acquires Shares of 26,800 Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Mon, 22 Sep 2025
10,700 Shares in Kiniksa Pharmaceuticals International, plc $KNSA Acquired by Toth Financial Advisory Corp - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 43 (M) |
| Shares Float | 34 (M) |
| Held by Insiders | 3.7 (%) |
| Held by Institutions | 93 (%) |
| Shares Short | 2,710 (K) |
| Shares Short P.Month | 2,430 (K) |
| EPS | 0.05 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.69 |
| Profit Margin | 0.8 % |
| Operating Margin | 12.8 % |
| Return on Assets (ttm) | 0.4 % |
| Return on Equity (ttm) | 1 % |
| Qtrly Rev. Growth | 44.2 % |
| Gross Profit (p.s.) | 6.46 |
| Sales Per Share | 12.17 |
| EBITDA (p.s.) | 0.13 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 67 (M) |
| Levered Free Cash Flow | 39 (M) |
| PE Ratio | 729.8 |
| PEG Ratio | 0 |
| Price to Book value | 5.45 |
| Price to Sales | 2.99 |
| Price to Cash Flow | 23.69 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|